MRNS
Marinus Pharmaceuticals Inc
Price:  
1.43 
USD
Volume:  
174,516.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNS WACC - Weighted Average Cost of Capital

The WACC of Marinus Pharmaceuticals Inc (MRNS) is 5.8%.

The Cost of Equity of Marinus Pharmaceuticals Inc (MRNS) is 6.50%.
The Cost of Debt of Marinus Pharmaceuticals Inc (MRNS) is 7.00%.

Range Selected
Cost of equity 5.50% - 7.50% 6.50%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.3% - 6.3% 5.8%
WACC

MRNS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.34 0.47
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 7.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.93 0.93
Cost of debt 7.00% 7.00%
After-tax WACC 5.3% 6.3%
Selected WACC 5.8%